(S1 (S (S (NP (NP (JJ Histopathological) (NN development)) (PP (IN of) (NP (JJ gastric) (NNS tumors)))) (VP (VBN induced) (PP (IN by) (NP (NP (NN N-methyl-N'-nitro-N-nitrosoguanidine)) (PP (IN in) (NP (NNS rats))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN development)) (PP (IN of) (NP (NN carcinoma)))) (VP (VBD was) (VP (VBN examined) (PP (IN in) (NP (NP (NP (JJ male) (NN Wistar) (NNS rats)) (PRN (-LRB- -LRB-) (NP (NN n) (JJ =) (CD 120)) (-RRB- -RRB-))) (VP (VBN exposed) (PP (TO to) (NP (NP (NN N-methyl-N'-nitro-N-nitrosoguanidine)) (PRN (-LRB- -LRB-) (NP (NN MNNG)) (-RRB- -RRB-)))) (PP (IN in) (NP (NP (NP (DT the) (JJ drinking) (NN water)) (PRN (-LRB- -LRB-) (NP (CD 83) (NN micrograms/ml)) (-RRB- -RRB-))) (PP (IN for) (NP (CD 16) (NNS weeks))))))))))) (. .)))
(S1 (S (S (PP (IN After) (NP (NN MNNG) (NN administration))) (, ,) (NP (NNS rats)) (VP (VBD were) (VP (VBN investigated) (PP (IN by) (NP (NP (JJ endoscopic) (NN observation)) (, ,) (NP (NP (NN visualization)) (PP (IN of) (NP (JJ microvascular) (NN structure)))) (, ,) (CC and) (NP (NP (NN estimation)) (PP (IN of) (NP (NN lectin) (NN binding) (NNS sites))))))))) (. .)))
(S1 (S (S (NP (NP (NNS Changes)) (PP (IN of) (NP (JJ bile) (NN reflux))) (PP (TO to) (NP (DT the) (NN stomach)))) (VP (VBD was) (VP (VBN observed) (ADVP (RB endoscopically)) (PP (PP (IN at) (NP (CD 24) (NNS weeks))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ gastric) (JJ mucosal) (NNS erosions)))))))) (. .)))
(S1 (S (S (NP (ADJP (ADJP (JJ Protruding)) (CC and) (ADJP (JJ expansive))) (JJ ulcerating) (NNS carcinomas)) (VP (VP (VBD developed) (PP (IN at) (NP (CD 36) (NNS weeks)))) (CC and) (VP (VBD had) (NP (NP (DT a) (JJ microvascular) (NN pattern)) (ADJP (JJ similar) (PP (TO to) (NP (NP (DT that)) (PP (IN of) (NP (JJ human) (NN adenocarcinoma)))))))))) (. .)))
(S1 (S (S (NP (NP (NN Estimation)) (PP (IN of) (NP (NP (NN lectin) (NN binding) (NN site)) (CC and) (NP (NN pattern))))) (VP (VBD was) (ADJP (JJ useful) (S (VP (TO to) (VP (VB evaluate) (NP (NP (DT the) (JJ malignant) (NN potential)) (PP (IN of) (NP (NN cell) (NN proliferation)))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP postulate) (SBAR (IN that) (S (S (NP (JJ endoscopic) (NN observation)) (VP (VBZ is) (ADJP (JJ valuable) (PP (IN in) (S (VP (VBG investigating) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (JJ gastric) (NN carcinoma)))))))))) (, ,) (CC and) (S (NP (NP (JJ microvascular) (NN structure)) (CC and) (NP (NN lectin) (NN binding) (NN pattern))) (VP (MD may) (VP (VB be) (ADJP (JJ useful) (S (VP (TO to) (VP (VB demonstrate) (NP (NP (DT the) (NN mechanism)) (PP (IN of) (NP (NP (NN growth)) (PP (IN of) (NP (JJ gastric) (NN carcinoma))))))))))))))))) (. .)))
